71.   Farber said the company is making a big push to develop the drug as a treatment for cancer.

72.   Foreign drug companies argue they need patent protection to recoup the huge amounts they spend on developing new drugs.

73.   For competitive reasons, all the companies declined to say which drugs they are developing.

74.   Genaissance, which identifies genetic markers for developing new drugs or refining existing ones, has gone that route.

75.   Genentech also just ended a collaboration with Inspire Pharmaceuticals to develop drugs for respiratory diseases.

76.   Genentech, its partner Xoma Ltd., and Biogen are furthest along in developing psoriasis drugs.

77.   Glaxo Wellcome said it intends to concentrate on developing prescription drugs.

78.   Guilford will also receive royalties on product sales and will have the option to develop one drug with Amgen.

79.   Guilford will receive royalties on product sales and will have the option to develop one drug with Amgen.

80.   Governments, doctors, consumers and insurers are pressing drug companies to keep prices down at a time when the cost of developing new drugs is rising rapidly.